Coronary Microvascular Disease: the Next Frontier in Ischemic Heart Disease

Marie Guerraty, MD, PhD, is currently an instructor in cardiovascular medicine at the University of Pennsylvania. Talk begins at:

Objectives:
1. Understand why Coronary Microvascular Disease (CMVD) is an important and prevalent clinical entity.
2. Draw from existing genomic and developmental research to gain insight into CMVD.
3. Understand how transcriptional coregulator Friend of GATA 2 (FOG2) may play a role in CMVD.

Follow Yale Cardiovascular Medicine on Twitter:
Sign up for email updates:

Yale,Cardiovascular Grand Rounds,Cardiovascular Medicine,medical grand rounds,cardiovascular disease,Grand Rounds,Cardiology,